Due to the study design as a case-control study, SOCS3 expression over the course of HBV infection were not assessed longitudinally and therefore the causative effect of SOCS3 expression on progression of HBV-related liver diseases could not conclusively be determined. Here, SOCS3 is linked to liver disorder.